Publicacions
-
Pérez-Rodríguez A, Batlle J, Corrales I, Borràs N, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Navarro N, Altisent C, Pérez-Montes R, Marcellini S, Moreto A, Herrero S, Soto I, Fernández Mosteirín N, Jiménez-Yuste V, Alonso N, de Andrés Jacob A, Fontanes E, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Castro Quismondo N, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, Tenorio M, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Dobón M, Aguilar C, Batlle F, Vidal F and López-Fernández MF.
Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project
PLoS One . 13(6): . Nº de cites: 5
-
Deyà-Martinez A, Esteve-Solé A, Vélez-Tirado N, Celis-Passini V, Costa-Colomer J, Cols M, Jou-Munoz C, Vlagea A, Plaza-Martín AM, Juan-Otero M and Alsina L.
Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T cells
PEDIATRIC ALLERGY AND IMMUNOLOGY . 29(4): 425-432. Nº de cites: 28
-
Maude SL, Laetsch TW, Buechner J, Rives-Solà S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA and Grupp SA.
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
NEW ENGLAND JOURNAL OF MEDICINE . 378(5): 439-448. Nº de cites: 3667
-
Llaudet-Planas E, Vives-Corrons JL, Rizzuto V, Gómez-Ramírez P, Sevilla Navarro J, Coll Sibina MT, García-Bernal M, Ruiz-Llobet A, Badell-Serra I, Velasco-Puyó P, Dapena JL and Mañú-Pereira MM.
Osmotic gradient ektacytometry: A valuable screening test for hereditary spherocytosis and other red blood cell membrane disorders.
INT J LAB HEMATOL . 40(1): 94-102. Nº de cites: 54
-
Lipka DB, Witte T, Toth R, Yang J, Wiesenfarth M, Nollke P, Fischer A, Brocks D, Gu Z, Park J, Strahm B, Wlodarski M, Yoshimi A, Claus R, Lubbert M, Busch H, Boerries M, Hartmann M, Schonung M, Kilik U, Langstein J, Wierzbinska JA, Pabst C, Garg S, Català-Temprano A, De Moerloose B, Dworzak M, Hasle H, Locatelli F, Masetti R, Schmugge M, Smith O, Stary J, Ussowicz M, van den Heuvel-Eibrink MM, Assenov Y, Schlesner M, Niemeyer C, Flotho C and Plass C.
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.
NATURE COMMUNICATIONS . 8(1): 2126-2126. Nº de cites: 84
-
Borràs N, Batlle J, Pérez-Rodríguez A, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jimimenez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Vidal F and Corrales I.
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients
HAEMATOLOGICA . 102(12): 2005-2014. Nº de cites: 38
-
Robles-Valero J, Lorenzo-Martín LF, Menacho-Márquez M, Fernández-Pisonero I, Abad A, Camós-Guijosa M, Toribio ML, Espinosa L, Bigas A and Bustelo XR.
A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia.
Cancer Cell . 32(5): 608-6239. Nº de cites: 29
-
Pascual-Pastó G, Gene-Olaciregui N, Opezzo JAW, Castillo-Ecija H, Cuadrado-Vilanova M, Paco-Mercader S, Rivero EM, Vilà-Ubach M, Restrepo-Perdomo CA, Torrebadell-Burriel M, Suñol M, Schaquevich P, Mora J, Bramuglia GF, Chantada G and Carcaboso AM.
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier
JOURNAL OF CONTROLLED RELEASE . 264: 34-44. Nº de cites: 13
-
Martínez-Valdez L, Deyà-Martinez A, Giner MT, Berrueco R, Esteve-Solé A, Juan M, Plaza-Martín AM and Alsina L.
Evans Syndrome as First Manifestation of Primary Immunodeficiency in Clinical Practice
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY . 39(7): 490-494. Nº de cites: 13
-
Bautista F, Gallego S, Cañete A, Mora J, Díaz de Heredia C, Cruz-Martínez O, Fernández JM, Rives-Solà S, Berlanga P, Hladun R, Juan Ribelles A, Madero L, Ramírez M, Fernández Delgado R, Pérez-Martínez A, Mata C, Llort A, Martín Broto J, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M, Moreno L and Sociedad Española de Hematología y Oncología Pediátrica (SEHOP).
Ensayos clínicos precoces en oncología pediátrica en España: una perspectiva nacional.
ANALES DE PEDIATRIA . 87(3): 155-163. Nº de cites: 2